• Wojciech Pluskiewicz, Piotr Adamczyk, and Bogna Drozdzowska.
• Department and Clinic of Internal Diseases, Diabetology, and Nephrology, Metabolic Bone Diseases Unit, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Katowice, Poland. wpluskiewicz@sum.edu.pl
• Pol. Arch. Med. Wewn. 2022 Oct 21; 132 (10).

IntroductionTherapeutic regimens for osteoporosis are the key elements in the management of osteoporotic patients.ObjectiveThe aim of the study was to present data on changes in osteoporosis therapy in women during a 10‑year follow‑up.Patients And MethodsWe analyzed a population‑based sample recruited in the RAC‑OST‑POL study. At baseline, the cohort included 978 women, of whom 541 remained in the follow‑up. Mean (SD) age of the patients was 74.7 (6.6) years.ResultsThe number of untreated women and those on alendronate decreased, while the number of patients receiving other forms of the antiresorptive therapy or calcium / vitamin D supplementation increased during the study. The percentage of untreated women in the rural areas and the urban areas was, respectively, 85% and 74.1% at baseline, and 74.3% and 63.3% at the end of the follow‑up. The percentage of untreated women decreased significantly, both in rural and urban cohorts. It was accompanied by a significant increase in calcium / vitamin D supplementation in both subgroups. Regarding the antiresorptive therapy, there was a significant increase in the frequency of its use only in the rural cohort. The use of therapeutic strategies was determined by the level of education. The frequency of calcium and / or vitamin D supplementation increased significantly in all education-related categories during the follow‑up.ConclusionChanges in the therapy of postmenopausal women with osteoporosis, observed in a 10‑year follow‑up of the RAC‑OST‑POL study, indicated that the level of care did not improve in this group of patients.

21 keywords...

hide…